Background Tumors of various sizes and locations can create a treatment dilemma in
achieving adequate surgical margins when sufficient free tissue is not available for closure …

OBJECTIVE To report the clinical use, adverse events, and outcomes after using amikacin in
30% poloxamer 407 (amikacin-P407) during open wound management or in a closed …

OBJECTIVE To compare the influence of fluid on carboplatin elution, and assess the
feasibility of ultrafiltration (UF) probe sampling SAMPLE 20 samples of 5 mg carboplatin in …

OBJECTIVE To compare the elution characteristics of amikacin-impregnated calcium sulfate
(CaSO 4) beads based on different drug concentrations and bead size configurations …

Objective To evaluate the intra‐lot and inter‐lot consistency and total carboplatin elution
over 25 days from carboplatin‐impregnated calcium sulfate hemihydrate (C‐I CSH) beads …

OBJECTIVE To characterize long-term elution of platinum from carboplatin-impregnated
calcium sulfate hemihydrate (CI-CSH) beads in vitro by comparing 2 distinct sample …

Objective To evaluate the pharmacokinetics (PK) of platinum (Pt) and safety of carboplatin‐
impregnated calcium sulfate hemihydrate (C‐I CSH) beads after implantation in healthy cats …

The objectives of this study were to evaluate a novel kit of resorbable calcium sulfate beads
marketed specifically for use in veterinary medicine and generally used for local delivery of …

Objective Evaluate local tissue toxicity and plasma platinum (Pt) in vivo after subcutaneous
implantation of carboplatin‐impregnated calcium sulfate hemihydrate (CI‐CSH) beads …

OBJECTIVE To characterize spatial release of platinum from carboplatin-impregnated
calcium sulfate hemihydrate (CI-CSH) beads by use of an agarose tissue phantom. SAMPLE …